Uttaniti Limchumroon

FDA investigator

Appears on 20 documents from 2015 to 2021, mostly at sites in California. Most often cites design and construction features (21 CFR 211.42).

20
Documents on file
7.0
Observations per 483
2015
First seen
2021
Most recent

What they cite most

From 135 observations

Activity by year

2015: 2, 2016: 2, 2017: 2, 2018: 2, 2019: 6, 2020: 3, 2021: 3

Where

California 14 · China 2 · Massachusetts 1 · Nevada 1 · Texas 1 · Washington 1

Often inspects with

Walden H. Lee· Lisa Shin· Evelyn Wong

Is Uttaniti Limchumroon coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

20 documents, newest first
FirmOpen
483 Med-Pharmex, IncSep 14, 2021 · Pomona, California
483 BioMarin Pharmaceutical Inc.Apr 2, 2021 · Novato, California
483 Diamond Wipes International, Inc.Mar 19, 2021 · Chino, California
483 Master Herbs, IncSep 14, 2020 · Pomona, California
483 B. Braun US Pharmaceutical Manufacturing LLCJul 23, 2020 · Irvine, California
483 B. Braun Medical IncJul 23, 2020 · Irvine, California
483 ABC Pharmacy, IncDec 20, 2019 · Encino, California

About this profile

What does Uttaniti Limchumroon inspect?

Uttaniti Limchumroon appears on 20 documents on file covering 18 sites, mostly in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Uttaniti Limchumroon is dated Sep 14, 2021.